Only two men can tell us if Elon Musk and Trump are truly, as of December 2025, “friends.” But the formal definition I used here is that they stop being friends “if one or the other publicly and ...

The U.S. Food and Drug Administration has approved a new indication for Breyanzi (lisocabtagene maraleucel) for treating adults with marginal zone lymphoma (MZL) who have failed treatment or relapsed ...

Your marginal tax rate is the highest tax rate you’ll pay on your income, based on your federal income tax bracket. Learn more about this tax rate. When thinking about federal income taxes, many ...

Bob revisits capital and interest theory to show why the textbook result “interest = MPK” only holds in a one-good world, and why in actual markets the interest rate emerges from time, prices, and ...

Horse Power: Led by drivers Lewis Hamilton and Charles Leclerc and team principal Frédéric Vasseur, Ferrari's Formula 1 team is now worth a series-high $6.5 billion. And Mercedes isn’t even sitting in ...

ByHeart, a manufacturer of organic baby formula, recalled all of its products sold nationwide Tuesday, days after some batches were recalled in an expanding outbreak of infant botulism. At least 15 ...

Is your feature request related to a problem? Please describe. It doesn't appear that there is an easy way to plot the marginal distribution for multivariate probability distributions. For example, ...

An error has occurred. Please try again. With a The Portland Press Herald subscription, you can gift 5 articles each month. It looks like you do not have any active ...

The Nigerian Upstream Petroleum Regulatory Commission (NUPRC) has completed a case-by-case review of the marginal fields licensing that are due for renewal. The exercise is a show of transparency and ...

Formula E popularity is surging. Season 10 saw a 23% increase in fans, reaching circa 374 million, while Season 11 is expected to surpass 500 million, and for good reason. It’s an intense and ...

The FDA accepted Breyanzi's sBLA for relapsed/refractory marginal zone lymphoma, granting priority review with a PDUFA date of December 5, 2025. Breyanzi is a CAR-T cell therapy targeting CD19, with a ...